BRIEF-Scilex Pharmaceuticals Enters Into Term Sheet With Virpax Pharmaceuticals

Reuters02-27

Feb 26 (Reuters) - Scilex Holding Co :

* SCILEX HOLDING COMPANY’S WHOLLY OWNED SUBSIDIARY, SCILEX PHARMACEUTICALS INC., ENTERS INTO A TERM SHEET WITH VIRPAX PHARMACEUTICALS, INC. REGARDING A MUTUAL RELEASE AND SETTLEMENT AGREEMENT

* SCILEX HOLDING CO - PARTIES AGREED TO ENTER DEFINITIVE SETTLEMENT AGREEMENT BY OR BEFORE MARCH 1, 2024 TO RESOLVE ONGOING DISPUTES

* SCILEX HOLDING CO - SETTLEMENT AGREEMENT RELATES TO ACTION FILED BY SCILEX PHARMA, SORRENTO AGAINST ANTHONY MACK AND VIRPAX

Source text for Eikon: Further company coverage:

((reuters.briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2414668508?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-02-27 06:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2414668508","market":"us","top_or_hot":-1,"title":"BRIEF-Scilex Pharmaceuticals Enters Into Term Sheet With Virpax Pharmaceuticals","media":"Reuters","content":"<html><body><p>Feb 26 (Reuters) - Scilex Holding Co   :</p><p>   * SCILEX HOLDING COMPANY’S WHOLLY OWNED SUBSIDIARY, SCILEX PHARMACEUTICALS INC., ENTERS INTO A TERM SHEET WITH VIRPAX PHARMACEUTICALS, INC. REGARDING A MUTUAL RELEASE AND SETTLEMENT AGREEMENT</p><p>   * SCILEX HOLDING CO - PARTIES AGREED TO ENTER DEFINITIVE SETTLEMENT AGREEMENT BY OR BEFORE MARCH 1, 2024 TO RESOLVE ONGOING DISPUTES</p><p>   * SCILEX HOLDING CO -  SETTLEMENT AGREEMENT RELATES TO ACTION FILED BY SCILEX PHARMA, SORRENTO AGAINST ANTHONY MACK AND VIRPAX</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((reuters.briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Scilex Pharmaceuticals Enters Into Term Sheet With Virpax Pharmaceuticals</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Scilex Pharmaceuticals Enters Into Term Sheet With Virpax Pharmaceuticals\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-27 06:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Feb 26 (Reuters) - Scilex Holding Co   :   * SCILEX HOLDING COMPANY’S WHOLLY OWNED SUBSIDIARY, SCILEX PHARMACEUTICALS INC., ENTERS INTO A TERM SHEET WITH VIRPAX PHARMACEUTICALS, INC. REGARDING A ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SCLX","symbol_name":"Scilex Holding Company","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2414668508","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2414668508","pubTimestamp":1708986868,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Feb 26  - Scilex Holding Co   :   * SCILEX HOLDING COMPANY’S WHOLLY OWNED SUBSIDIARY, SCILEX PHARMACEUTICALS INC., ENTERS INTO A TERM SHEET WITH VIRPAX PHARMACEUTICALS, INC. REGARDING A MUTUAL RELEASE AND SETTLEMENT AGREEMENT   * SCILEX HOLDING CO - PARTIES AGREED TO ENTER DEFINITIVE SETTLEMENT AGREEMENT BY OR BEFORE MARCH 1, 2024 TO RESOLVE ONGOING DISPUTES   * SCILEX HOLDING CO -  SETTLEMENT AGREEMENT RELATES TO ACTION FILED BY SCILEX PHARMA, SORRENTO AGAINST ANTHONY MACK AND VIRPAXSource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SCLX":"Scilex Holding Company","BK4007":"制药","VRPX":"Virpax Pharmaceuticals, Inc."},"translate_title":"简介-Scilex Pharmaceuticals与Virpax Pharmaceuticals签订条款清单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VRPX":1,"SCLX":0.9},"content_text":"Feb 26 (Reuters) - Scilex Holding Co   :   * SCILEX HOLDING COMPANY’S WHOLLY OWNED SUBSIDIARY, SCILEX PHARMACEUTICALS INC., ENTERS INTO A TERM SHEET WITH VIRPAX PHARMACEUTICALS, INC. REGARDING A MUTUAL RELEASE AND SETTLEMENT AGREEMENT   * SCILEX HOLDING CO - PARTIES AGREED TO ENTER DEFINITIVE SETTLEMENT AGREEMENT BY OR BEFORE MARCH 1, 2024 TO RESOLVE ONGOING DISPUTES   * SCILEX HOLDING CO -  SETTLEMENT AGREEMENT RELATES TO ACTION FILED BY SCILEX PHARMA, SORRENTO AGAINST ANTHONY MACK AND VIRPAXSource text for Eikon:    Further company coverage:    ((reuters.briefs@thomsonreuters.com;))","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2414668508"}